Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
The Meet Group to Present at Upcoming Investor Conferences
-
Etsy to Present at Upcoming Investor Conferences
-
Health Insurance Innovations (HIIQ) PT Raised to $62 at Canaccord Genuity
-
FARO to Present at Canaccord Genuity 2018 Growth Conference
-
Mogo to Present at Canaccord Genuity Growth Conference
-
Edwards Lifesciences To Present at 38th Annual Canaccord Genuity Growth Conference
-
Obalon Therapeutics (OBLN) PT Lowered to $2.50 at Canaccord Genuity; Keeps 'Buy'
-
Misonix to Present at the 38th Annual Canaccord Genuity Growth Conference on August 8
-
ShotSpotter to Present at Canaccord Genuity 38th Annual Growth Conference on August 8, 2018
-
Canaccord Genuity Upgrades Quarterhill Inc. (QTRH) to Spec. Buy Citing 'Huge' Patent Win Vs. Apple (AAPL)
-
EXFO to present at Canaccord Genuity's growth conference
-
SharpSpring to Present at Canaccord Genuity 38th Annual Growth Conference on August 8, 2018 at 9:00 a.m. ET
-
Dolphin Entertainment to Present at the 38th Annual Canaccord Genuity Growth Conference
-
AquaVenture Holdings Limited to Participate at Upcoming Investor Conferences
-
Green Thumb Industries Announces Closing of CAD$80.3 Million Bought Deal Financing
-
Ampio Pharmaceuticals, Inc. to Present at the 38th Annual Canaccord Genuity Growth Conference
-
Voyager Therapeutics to Present at Investor Conferences in August
-
Forty Seven Inc. to Present at the 38th Annual Canaccord Genuity Growth Conference
-
Lipocine to Present at the Canaccord Genuity 38th Annual Growth Conference
-
BioXcel Therapeutics to Present at the 38th Annual Canaccord Genuity Growth Conference
-
Alder BioPharmaceuticals® to Present at the Canaccord Genuity 38th Annual Growth Conference
-
Daré Bioscience, Inc. to Present at the Canaccord Genuity 38th Annual Growth Conference
-
Forty Seven Inc. to Present at the 38th Annual Canaccord Genuity Growth Conference
-
Alder BioPharmaceuticals® to Present at the Canaccord Genuity 38th Annual Growth Conference
-
Daré Bioscience, Inc. to Present at the Canaccord Genuity 38th Annual Growth Conference
-
Selecta Biosciences to Present at the Canaccord Growth Conference on August 9, 2018
-
NAPCO Security Technologies to Present at the Canaccord Genuity Growth Conference on August 9, 2018
-
SendGrid to Present at Upcoming Investor Conferences
-
Aerie Pharmaceuticals to Present at the Canaccord Genuity Growth Conference
-
Aptose Biosciences to Present at Canaccord Genuity 38th Annual Growth Conference
-
Karyopharm to Participate in Upcoming Investor Conferences
-
Aileron Therapeutics to Present at the Canaccord Genuity 38th Annual Growth Conference
-
Aileron Therapeutics to Present at the Canaccord Genuity 38th Annual Growth Conference
-
Karyopharm to Participate in Upcoming Investor Conferences
-
EyePoint Pharmaceuticals to Present at the 38th Annual Canaccord Genuity Growth Conference
-
Coeur Mining to Acquire Northern Empire Resources
-
Sesen Bio to Present at the Canaccord Genuity 38th Annual Growth Conference
-
Canaccord Genuity Downgrades Red Robin Gourmet Burgers (RRGB) to Hold
-
Canaccord Genuity Group Inc. Reports First Quarter Fiscal 2019 Results
-
AxoGen, Inc. Reports 2018 Second Quarter Financial Results
-
AxoGen, Inc. Reports 2018 Second Quarter Financial Results
-
Zafgen to Present at the Canaccord Genuity 38th Annual Growth Conference
-
SPS Commerce to Present at Investor Conferences
-
Telaria to Present at the Canaccord Genuity 38th Annual Growth Conference
-
Zafgen to Present at the Canaccord Genuity 38th Annual Growth Conference
-
LeMaitre Vascular to Present at Upcoming Investor Conferences
-
SPS Commerce to Present at Investor Conferences
-
HTG Molecular Diagnostics to Present at Canaccord Genuity Growth Conference
-
Blueprint Medicines to Present at Upcoming Investor Conferences in August
-
Alkermes' Corporate Presentation to be Webcast at the 38th Annual Canaccord Genuity Growth Conference

